Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Inmode Ltd (INMD)

59.95   2.23 (3.86%) 01-21 01:00
Open: 58.66 Pre. Close: 57.72
High: 61.81 Low: 58.66
Volume: 751,671 Market Cap: 1,966M
InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radio frequency technologies. The company offers minimally-invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. InMode Ltd. offers its products directly in the United States, Canada, the United Kingdom, Spain, Australia, and India, as well as indirectly through distributors in 46 countries. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was founded in 2008 and is headquartered in Yokneam, Israel.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 61.88 - 62.126 62.126 - 62.337
Low: 58.001 - 58.295 58.295 - 58.549
Close: 59.439 - 59.922 59.922 - 60.338

Technical analysis

as of: 2021-01-20 4:48:44 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 72.19     One year: 84.32
Support: Support1: 51.14    Support2: 44.55
Resistance: Resistance1: 61.81    Resistance2: 72.19
Pivot: 51.54
Moving Average: MA(5): 57.47     MA(20): 50.53
MA(100): 41.66     MA(250): 34.73
MACD: MACD(12,26): 3.47     Signal(9): 2.46
Stochastic oscillator: %K(14,3): 89.50     %D(3): 90.45
RSI: RSI(14): 82.77
52-week: High: 61.81  Low: 13.14  Change(%): 20.5
Average Vol(K): 3-Month: 66531  10-Days: 88273

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
INMD has closed below upper band by 4.1%. Bollinger Bands are 195.9% wider than normal. The large width of the bands suggest high volatility as compared to INMD's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue.

Headline News

Sun, 17 Jan 2021
Validea's Top Five Healthcare Stocks Based On Motley Fool - 1/17/2021 - Nasdaq

Tue, 12 Jan 2021
InMode Expects Record Fourth Quarter and Full Year 2020 Results, Fourth Quarter Revenue Between $74.5-$75M, Non-GAAP Earnings per Diluted Share Between $0.91-$0.93; Announces 2021 Full Year Revenue Guidance of $250- $260M - Yahoo Finance

Mon, 11 Jan 2021
InMode to Participate at the 2021 ICR Conference - Yahoo Finance

Mon, 11 Jan 2021
Zacks.com featured highlights include: Azure Power Global, Mueller Industries, H&E Equipment Services, Korea Electric Power and InMode - Yahoo Finance

Wed, 06 Jan 2021
InMode Announces Corporate Social Responsibility Strategy USA - PRNewswire

Sun, 03 Jan 2021
A Multi-Bagger Stock In The Making: InMode Has All The Right Traits - Seeking Alpha

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Outperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 33
Shares Float (M) 17
% Held by Insiders 42.45
% Held by Institutions 45.32
Shares Short (K) 1,580
Shares Short P. Month (K) 1,620

Stock Financials

EPS 1.160
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 5.300
Profit Margin 32.57
Operating Margin 31.13
Return on Assets (ttm) 14.9
Return on Equity (ttm) 29.5
Qtrly Rev. Growth 49.2
Gross Profit (p.s.) 4.150
Sales Per Share 5.424
EBITDA (p.s.) 1.700
Qtrly Earnings Growth 47.60
Operating Cash Flow (M) 65
Levered Free Cash Flow (M) 42

Stock Valuations

PE Ratio 51.68
PEG Ratio
Price to Book value 11.31
Price to Sales 11.05
Price to Cash Flow 30.22

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.